ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01BA05 | B | Pralatrexate - 20mg/ml | 7978 | 107614/1 | FOLOTYN | 20mg/ml | 1 | Injectable solution | Infusion | Mersaco | Baxter Oncology GmbH | Germany | 5,629,013 L.L | 2.44 | E2 | Mundipharma Medical Company | Switzerland | 05/02/20 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01BA05 | B | Pralatrexate - 20mg/ml | 7978/945 | 107614/1 | FOLOTYN | 20mg/ml | 1 | Injectable solution | Infusion | Mersaco | Baxter Oncology GmbH | Germany | 343,181,552 L.L | 2.44 | E2 | Mundipharma Medical Company | Switzerland | 05/02/20 | 0 |